163 related articles for article (PubMed ID: 11085933)
1. A single amino acid substitution (N297A) in the conserved NPXXY sequence of the human N-formyl peptide receptor results in inhibition of desensitization and endocytosis, and a dose-dependent shift in p42/44 mitogen-activated protein kinase activation and chemotaxis.
Gripentrog JM; Jesaitis AJ; Miettinen HM
Biochem J; 2000 Dec; 352 Pt 2(Pt 2):399-407. PubMed ID: 11085933
[TBL] [Abstract][Full Text] [Related]
2. Differential roles of the NPXXY motif in formyl peptide receptor signaling.
He R; Browning DD; Ye RD
J Immunol; 2001 Mar; 166(6):4099-105. PubMed ID: 11238659
[TBL] [Abstract][Full Text] [Related]
3. Experimental evidence for lack of homodimerization of the G protein-coupled human N-formyl peptide receptor.
Gripentrog JM; Kantele KP; Jesaitis AJ; Miettinen HM
J Immunol; 2003 Sep; 171(6):3187-93. PubMed ID: 12960347
[TBL] [Abstract][Full Text] [Related]
4. Identification of putative sites of interaction between the human formyl peptide receptor and G protein.
Miettinen HM; Gripentrog JM; Mason MM; Jesaitis AJ
J Biol Chem; 1999 Sep; 274(39):27934-42. PubMed ID: 10488141
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the binding site on the formyl peptide receptor using three receptor mutants and analogs of Met-Leu-Phe and Met-Met-Trp-Leu-Leu.
Mills JS; Miettinen HM; Cummings D; Jesaitis AJ
J Biol Chem; 2000 Dec; 275(50):39012-7. PubMed ID: 10960471
[TBL] [Abstract][Full Text] [Related]
6. The synthetic peptide Trp-Lys-Tyr-Met-Val-D-Met is a potent chemotactic agonist for mouse formyl peptide receptor.
He R; Tan L; Browning DD; Wang JM; Ye RD
J Immunol; 2000 Oct; 165(8):4598-605. PubMed ID: 11035102
[TBL] [Abstract][Full Text] [Related]
7. Activation and nuclear translocation of ERK1/2 by the formyl peptide receptor is regulated by G protein and is not dependent on beta-arrestin translocation or receptor endocytosis.
Gripentrog JM; Miettinen HM
Cell Signal; 2005 Oct; 17(10):1300-11. PubMed ID: 16038804
[TBL] [Abstract][Full Text] [Related]
8. Mutations of F110 and C126 of the formyl peptide receptor interfere with G-protein coupling and chemotaxis.
Jones BE; Miettinen HM; Jesaitis AJ; Mills JS
J Periodontol; 2003 Apr; 74(4):475-84. PubMed ID: 12747452
[TBL] [Abstract][Full Text] [Related]
9. Chemotaxis of chinese hamster ovary cells expressing the human neutrophil formyl peptide receptor: role of signal transduction molecules and alpha5beta1 integrin.
Miettinen HM; Gripentrog JM; Jesaitis AJ
J Cell Sci; 1998 Jul; 111 ( Pt 14)():1921-8. PubMed ID: 9645940
[TBL] [Abstract][Full Text] [Related]
10. Normal cell surface expression and selective loss of functions resulting from Phe110 to Ser and Cys126 to Trp substitutions in the formyl peptide receptor.
Nanamori M; He R; Sang H; Ye RD
Immunol Invest; 2004 May; 33(2):193-212. PubMed ID: 15195697
[TBL] [Abstract][Full Text] [Related]
11. Identification of a ligand binding site in the human neutrophil formyl peptide receptor using a site-specific fluorescent photoaffinity label and mass spectrometry.
Mills JS; Miettinen HM; Barnidge D; Vlases MJ; Wimer-Mackin S; Dratz EA; Sunner J; Jesaitis AJ
J Biol Chem; 1998 Apr; 273(17):10428-35. PubMed ID: 9553101
[TBL] [Abstract][Full Text] [Related]
12. Dexras1/AGS-1 inhibits signal transduction from the Gi-coupled formyl peptide receptor to Erk-1/2 MAP kinases.
Graham TE; Prossnitz ER; Dorin RI
J Biol Chem; 2002 Mar; 277(13):10876-82. PubMed ID: 11751935
[TBL] [Abstract][Full Text] [Related]
13. Differential activation of formyl peptide receptor signaling by peptide ligands.
Bae YS; Song JY; Kim Y; He R; Ye RD; Kwak JY; Suh PG; Ryu SH
Mol Pharmacol; 2003 Oct; 64(4):841-7. PubMed ID: 14500740
[TBL] [Abstract][Full Text] [Related]
14. The ligand binding site of the formyl peptide receptor maps in the transmembrane region.
Miettinen HM; Mills JS; Gripentrog JM; Dratz EA; Granger BL; Jesaitis AJ
J Immunol; 1997 Oct; 159(8):4045-54. PubMed ID: 9378994
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylation of the N-formyl peptide receptor is required for receptor internalization but not chemotaxis.
Hsu MH; Chiang SC; Ye RD; Prossnitz ER
J Biol Chem; 1997 Nov; 272(47):29426-9. PubMed ID: 9367998
[TBL] [Abstract][Full Text] [Related]
16. Internalization of the human N-formyl peptide and C5a chemoattractant receptors occurs via clathrin-independent mechanisms.
Gilbert TL; Bennett TA; Maestas DC; Cimino DF; Prossnitz ER
Biochemistry; 2001 Mar; 40(12):3467-75. PubMed ID: 11297412
[TBL] [Abstract][Full Text] [Related]
17. Arrestin binding to the G protein-coupled N-formyl peptide receptor is regulated by the conserved "DRY" sequence.
Bennett TA; Maestas DC; Prossnitz ER
J Biol Chem; 2000 Aug; 275(32):24590-4. PubMed ID: 10823817
[TBL] [Abstract][Full Text] [Related]
18. The thyrotropin receptor is not involved in the activation of p42/p44 mitogen-activated protein kinases by thyrotropin preparations in Chinese hamster ovary cells expressing the human thyrotropin receptor.
Corrèze C; Blondeau JP; Pomerance M
Thyroid; 2000 Sep; 10(9):747-52. PubMed ID: 11041451
[TBL] [Abstract][Full Text] [Related]
19. Formyl peptide receptors are coupled to multiple mitogen-activated protein kinase cascades by distinct signal transduction pathways: role in activation of reduced nicotinamide adenine dinucleotide oxidase.
Rane MJ; Carrithers SL; Arthur JM; Klein JB; McLeish KR
J Immunol; 1997 Nov; 159(10):5070-8. PubMed ID: 9366435
[TBL] [Abstract][Full Text] [Related]
20. The endogenous opioid spinorphin blocks fMet-Leu-Phe-induced neutrophil chemotaxis by acting as a specific antagonist at the N-formylpeptide receptor subtype FPR.
Liang TS; Gao JL; Fatemi O; Lavigne M; Leto TL; Murphy PM
J Immunol; 2001 Dec; 167(11):6609-14. PubMed ID: 11714831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
